SBFM is in the process of completing their IND stu

SBFM is in the process of completing their IND studies at which point they will be able to complete the IND application to allow clinical trials to begin on humans.

almost all of the shares outside the float are restricted and they conduct research in Canada where they get tax credits so are able to do much more for the same amount of money

Sunshine Biopharma is a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company's lead anti-cancer compound, Adva-27a, is currently in late stage preclinical studies.